Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 10/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20815767 | 0.75 | PLK1 (0.55) | ALDH1A1MAPT | |
| SCHEMBL12127779 | 0.73 | HDAC1 (0.65) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL13753321 | 0.73 | ALDH1A1 (0.61) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL963723 | 0.72 | HDAC1 (0.61) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL17404990 | 0.71 | HDAC1 (0.72) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL4432658 | 0.71 | HDAC1 (0.60) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL22015906 | 0.71 | HDAC1 (0.71) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| Butane SCHEMBL11690769 | 0.71 | MAPT (0.57) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL11246236 | 0.70 | KDM4E (0.61) | HDAC1HDAC8HDAC2HDAC3HDAC11 | |
| SCHEMBL6674162 | 0.70 | HDAC6 (0.89) | HDAC1HDAC8HDAC2HDAC3HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205436-B2 | Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines | GALAXY SURFACTANTS LIMITED (IN) | 2007-04-17 | — | — | US | disclosed |
| US-7045139-B2 | Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines | GALAXY SURFACTANTS LIMITED (IN) | 2006-05-16 | — | — | US | disclosed |
| US-20050209327-A1 | Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines | GALAXY SURFACTANTS LTD. (IN) | 2005-09-22 | — | — | US | disclosed |
| US-20050080135-A1 | Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines | GALAXY SURFACTANTS LTD. (IN) | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209327-A1 | Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines | NISCH, CUTA, PFAS | HDAC1 1160/4885HDAC8 2363/4885HDAC2 2064/4885 |
| US-20050080135-A1 | Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines | NISCH, CUTA, PFAS | HDAC1 1160/4885HDAC8 2363/4885HDAC2 2064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.